Adult Immunization

  • David S. Fedson


Among all of the challenges of clinical preventive medicine, immunization offers the most clear-cut benefits and greatest likelihood for success. Nonetheless, vaccines often are not regarded as examples of high-technology medical care (which they are),1 and their use among adults has not been widespread. In contrast, almost all children in the United States receive their required childhood immunizations by the time of school entry. So successful has this been that a substantial proportion of the remaining morbidity and mortality from these vaccine-preventable diseases of childhood now occurs in older adolescents and adults. Thus successful implementation of adult immunization programs is still one of the major challenges in prevention facing physicians.


Influenza Vaccine Tetanus Toxoid Pneumococcal Vaccine Pneumococcal Infection Measle Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Thomas, L.: The technology of medicine. N. Engl. J. Med. 285: 1365–1368, 1971.CrossRefGoogle Scholar
  2. 2.
    Committee on Immunization: Guide for Adult Immunization. American College of Physicians, Philadelphia, 1985.Google Scholar
  3. 3.
    Fedson, D. S.: Immunizations for health care workers and patients in hospitals, in Wenzel, R. P. (ed.): Prevention and Control of Nosocomial Infections. Williams & Wilkins, Baltimore, 1986, pp. 116–174.Google Scholar
  4. 4.
    Fedson D. S.: Adult Immunization, in Noble J. (ed.): Textbook of General Medicine and Primary Care. Little, Brown, Boston, 1987, pp. 1681–1695.Google Scholar
  5. 5.
    Perrotta, D. M., Decker, M., and Glezen, W. P.: Acute respiratory disease hospitalization as a measure of impact of epidemic influenza. Am. J. Epidemiol. 122: 468–476, 1985.PubMedGoogle Scholar
  6. 6.
    Barker, W. H.: Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am. J. Public Health 76: 761–765, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Lui, K.J., and Kendal, A. P.: Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health, 77: 712–716, 1987.PubMedCrossRefGoogle Scholar
  8. 8.
    Fedson, D. S.: Influenza and pneumococcal immunization strategies for physicians. Chest 91: 436–443, 1987.PubMedCrossRefGoogle Scholar
  9. 9.
    Riddiough, M. A., Sisk, J. E., and Bell, J. C.: Influenza vaccination. Cost effectiveness and public policy. JAMA 249: 3189–3195, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Research Committee of the British Thoracic Society and the Public Health Laboratory Service: Community-acquired pneumonia in adults in British hopsitals in 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome. Q. J. Med. 62: 195–220, 1987.Google Scholar
  11. 11.
    Fedson, D.S.: Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: A review of its rationale and implications. J. Am. Geriatr. Soc. 33: 142–150, 1985.PubMedGoogle Scholar
  12. 12.
    Shapiro, E. D., and Clemens, J. D.: A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann. Intern. Med. 101: 325–330, 1984.PubMedGoogle Scholar
  13. 13.
    Bolan, G., Broome, C. V., Facklam, R. R., et al.: Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104: 1–6, 1986.PubMedGoogle Scholar
  14. 14.
    Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., et al.: Efficacy of pneumococcal vaccine: Results of a Veterans Administration cooperative study. N. Engl. J. Med. 315: 1318–1327, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Centers for Disease Control: Annual Summary 1984: Reported morbidity and mortality in the United States. Morbid. Mortal. Wkly. Rep. 33(54): 3, 1986.Google Scholar
  16. 16.
    Hinman, A. R., Eddins, D. L., Kirby, C. D., et al.: Progress in measles elimination. JAMA 247: 1592–1595, 1982.PubMedCrossRefGoogle Scholar
  17. 17.
    Orenstein, W. A., Bart, K. J., Hinman, A. R., et al.: The opportunity and obligation to eliminate rubella from the United States. JAMA 251: 1988–1994, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    White, C. C., Koplan, J. P., and Orenstein, W. A.: Benefits, risks and costs of immunization for measles, mumps and rubella. Am. J. Public Health 75: 739–744, 1985.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim-Farley, R. J., Bart, K. J., Schonberger, L. B., et al.: Poliomyelitis in the USA: Virtual elimination of disease caused by wild virus. Lancet 2: 1315–1317, 1984.PubMedCrossRefGoogle Scholar
  20. 20.
    Weiss, B. P., Strassburg, M. A., and Feeny, J. C.: Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am. J. Public Health 73: 802–804, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Brand, D. A., Acampora, D., Gottlieb, L. D., et al.: Adequacy of antitetanus prophylaxis in six hospital emergency rooms. N. Engl. J. Med. 309: 636–640, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • David S. Fedson
    • 1
  1. 1.Department of Internal MedicineUniversity of Virginia School of MedicineCharlottesvilleUSA

Personalised recommendations